Literature DB >> 17823651

The 5HTTLPR polymorphism, prior maltreatment and dramatic-erratic personality manifestations in women with bulimic syndromes.

Howard Steiger1, Jodie Richardson, Ridha Joober, Lise Gauvin, Mimi Israel, Kenneth R Bruce, N M K Ng Ying Kin, Heidi Howard, Simon N Young.   

Abstract

BACKGROUND: Low-function alleles of the serotonin transporter promoter polymorphism (5HTTLPR) have been linked to various psychopathological entities, especially in individuals exposed to prior stressors. In women with bulimic syndromes, we explored associations with personality pathology of 5HTTLPR and prior sexual or physical maltreatment.
METHODS: Ninety-two women with bulimic syndromes were genotyped for 5HTTLPR short (S) and long (L(G) and L(A)) alleles and were then assessed for eating symptoms, dimensional personality disturbances, history of sexual or physical abuse and borderline personality disorder (BPD).
RESULTS: With a classification based on a biallelic model of 5HTTLPR (i.e., presence or absence of at least 1 S-allele copy), multiple regression analyses indicated significant proportions of variance in stimulus seeking and insecure attachment to be explained by abuse x genotype interaction effects, with greater psychopathology always occurring in S-allele carriers who had been abused. Likewise, a logistic regression analysis linked BPD to significant main effects of genotype and abuse. Analyses that aggregated carriers according to a triallelic model of 5HTTLPR (i.e., presence or absence of at least 1 copy of a presumably low-function S or LG allele) produced similar patterns but no statistically significant effects.
CONCLUSIONS: Traits such as sensation seeking and insecure attachment are, on average, elevated in 5HTTLPR S-allele carriers with bulimic syndromes who report prior physical or sexual maltreatment. These results add to the literature associating pronounced psychopathological manifestations, with conjoint effects of stress and the 5HTTLPR polymorphism.

Entities:  

Keywords:  bulimia nervosa; genotypes; serotonin

Mesh:

Substances:

Year:  2007        PMID: 17823651      PMCID: PMC1963352     

Source DB:  PubMed          Journal:  J Psychiatry Neurosci        ISSN: 1180-4882            Impact factor:   6.186


  36 in total

1.  Serotonin transporter linked polymorphic region in anorexia nervosa and bulimia nervosa.

Authors:  D D Di Bella; M Catalano; M C Cavallini; C Riboldi; L Bellodi
Journal:  Mol Psychiatry       Date:  2000-05       Impact factor: 15.992

2.  Personality subtyping and bulimia nervosa: psychopathological and genetic correlates.

Authors:  Stephen A Wonderlich; Ross D Crosby; Thomas Joiner; Carol B Peterson; Anna Bardone-Cone; Marjorie Klein; Scott Crow; James E Mitchell; Daniel Le Grange; Howard Steiger; Greg Kolden; Frank Johnson; Suzanne Vrshek
Journal:  Psychol Med       Date:  2005-05       Impact factor: 7.723

Review 3.  Personality and eating disorders: a decade in review.

Authors:  Stephanie E Cassin; Kristin M von Ranson
Journal:  Clin Psychol Rev       Date:  2005-11

4.  Association of a triallelic serotonin transporter gene promoter region (5-HTTLPR) polymorphism with stressful life events and severity of depression.

Authors:  Gil Zalsman; Yung-Yu Huang; Maria A Oquendo; Ainsley K Burke; Xian-Zhang Hu; David A Brent; Steven P Ellis; David Goldman; J John Mann
Journal:  Am J Psychiatry       Date:  2006-09       Impact factor: 18.112

5.  [123I] beta-CIT and single photon emission computed tomography reveal reduced brain serotonin transporter availability in bulimia nervosa.

Authors:  J Tauscher; W Pirker; M Willeit; M de Zwaan; U Bailer; A Neumeister; S Asenbaum; C Lennkh; N Praschak-Rieder; T Brücke; S Kasper
Journal:  Biol Psychiatry       Date:  2001-02-15       Impact factor: 13.382

6.  Serotonin transporter promoter gain-of-function genotypes are linked to obsessive-compulsive disorder.

Authors:  Xian-Zhang Hu; Robert H Lipsky; Guanshan Zhu; Longina A Akhtar; Julie Taubman; Benjamin D Greenberg; Ke Xu; Paul D Arnold; Margaret A Richter; James L Kennedy; Dennis L Murphy; David Goldman
Journal:  Am J Hum Genet       Date:  2006-03-28       Impact factor: 11.025

7.  Reduced density of platelet-binding sites for [3H]paroxetine in remitted bulimic women.

Authors:  Howard Steiger; Jodie Richardson; Mimi Israel; N M K Ng Ying Kin; Kenneth Bruce; Sandra Mansour; Anne Marie Parent
Journal:  Neuropsychopharmacology       Date:  2005-05       Impact factor: 7.853

8.  Serotonergic blunting to meta-chlorophenylpiperazine (m-CPP) highly correlates with sustained childhood abuse in impulsive and autoaggressive female borderline patients.

Authors:  T Rinne; H G Westenberg; J A den Boer; W van den Brink
Journal:  Biol Psychiatry       Date:  2000-03-15       Impact factor: 13.382

9.  Association between serotonin transporter gene and borderline personality disorder.

Authors:  Xingqun Ni; Kirsten Chan; Natalie Bulgin; Tricia Sicard; Ramprasad Bismil; Shelley McMain; James L Kennedy
Journal:  J Psychiatr Res       Date:  2006-05-11       Impact factor: 4.791

10.  Intrafamilial correspondences on platelet [3H-]paroxetine-binding indices in bulimic probands and their unaffected first-degree relatives.

Authors:  Howard Steiger; Lise Gauvin; Ridha Joober; Mimi Israel; N M K Ng Ying Kin; Kenneth R Bruce; Jodie Richardson; Simon N Young; Julie Hakim
Journal:  Neuropsychopharmacology       Date:  2006-01-11       Impact factor: 7.853

View more
  19 in total

Review 1.  Developmental pathways to borderline personality disorder.

Authors:  Andrew M Chanen; Michael Kaess
Journal:  Curr Psychiatry Rep       Date:  2012-02       Impact factor: 5.285

2.  Association between the serotonin transporter triallelic genotype and eating problems is moderated by the experience of childhood trauma in women.

Authors:  Scott F Stoltenberg; Cynthia Anderson; Parthasarathi Nag; Cheryl Anagnopoulos
Journal:  Int J Eat Disord       Date:  2012-01-23       Impact factor: 4.861

Review 3.  Current status of functional imaging in eating disorders.

Authors:  Guido K W Frank; Walter H Kaye
Journal:  Int J Eat Disord       Date:  2012-04-25       Impact factor: 4.861

Review 4.  Behavioral and neurodevelopmental precursors to binge-type eating disorders: support for the role of negative valence systems.

Authors:  A Vannucci; E E Nelson; D M Bongiorno; D S Pine; J A Yanovski; M Tanofsky-Kraff
Journal:  Psychol Med       Date:  2015-06-04       Impact factor: 7.723

Review 5.  Role of eating disorders-related polymorphisms in obesity pathophysiology.

Authors:  Carolina Ferreira Nicoletti; Heitor Bernardes Pereira Delfino; Flávia Campos Ferreira; Marcela Augusta de Souza Pinhel; Carla Barbosa Nonino
Journal:  Rev Endocr Metab Disord       Date:  2019-03       Impact factor: 6.514

Review 6.  A systematic review and secondary data analysis of the interactions between the serotonin transporter 5-HTTLPR polymorphism and environmental and psychological factors in eating disorders.

Authors:  Vanja Rozenblat; Deborah Ong; Matthew Fuller-Tyszkiewicz; Kirsti Akkermann; David Collier; Rutger C M E Engels; Fernando Fernandez-Aranda; Jaanus Harro; Judith R Homberg; Andreas Karwautz; Evelyn Kiive; Kelly L Klump; Christine L Larson; Sarah E Racine; Jodie Richardson; Howard Steiger; Scott F Stoltenberg; Tatjana van Strien; Gudrun Wagner; Janet Treasure; Isabel Krug
Journal:  J Psychiatr Res       Date:  2016-09-24       Impact factor: 4.791

7.  Genetics and Epigenetics of Eating Disorders.

Authors:  Zeynep Yilmaz; J Andrew Hardaway; Cynthia M Bulik
Journal:  Adv Genomics Genet       Date:  2015-03-10

8.  Genetic variation in the serotonin transporter and HTR1B receptor predicts reduced bone formation during serotonin reuptake inhibitor treatment in older adults.

Authors:  Lauren D Garfield; Daniel J Müller; James L Kennedy; Benoit H Mulsant; Charles F Reynolds; Steven L Teitelbaum; Roberto Civitelli; David Dixon; Alexandre A Todorov; Eric J Lenze
Journal:  World J Biol Psychiatry       Date:  2013-09-30       Impact factor: 4.132

9.  Validating new summary indices for the Childhood Trauma Interview: associations with first onsets of major depressive disorder and anxiety disorders.

Authors:  Suzanne Vrshek-Schallhorn; Kate Wolitzky-Taylor; Leah D Doane; Alyssa Epstein; Jennifer A Sumner; Susan Mineka; Richard E Zinbarg; Michelle G Craske; Ashley Isaia; Constance Hammen; Emma K Adam
Journal:  Psychol Assess       Date:  2014-05-12

10.  Clinical implications of genetic variation in the serotonin transporter promoter region: a review.

Authors:  Nicole S Luddington; Anitha Mandadapu; Margaret Husk; Rif S El-Mallakh
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2009
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.